Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol + ketamine vs propofol + remifentanil for deep sedation and analgesia in children with acute lymphoblastic leukemia undergoing painful procedures
IRCT2017080935601N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of propofol, ketamine and remifentanil in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by Isfahan University of Medical Sciences. Started Sep 2016; status: completed.
02
Drugs
propofolketamineremifentanil
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on IRCT2017080935601N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017080935601N1.